Interview: Paweł Mazur – East Area Director, Accord Healthcare, Poland
As east area director for the vast CEE market, Pawel Mazur explains how Accord Healthcare has gone from strength to strength in Poland, with the intention of becoming a top…
Address: Rydygiera 8, 01-793 Warsaw, Poland
Tel: +48 22 456 39 00
PRI – Pharmaceutical Research Institute in Warsaw, Poland, is a government-owned R&D organization. PRI’s main areas of activity include: research and development in the area of pharmaceutical sciences, as well as manufacturing of medicinal products and selected active pharmaceutical ingredients (APIs) in laboratory and production scale. The lists of commercializations, patents, scientific papers and prizes awarded to PRI staff is presented in the references section.
The key assets of Pharmaceutical Research Institute include:
Specialists – highly educated and well-trained staff with extensive experience in chemical and pharmaceutical research.
Quality – R&D activities, commercializations, manufacturing and documentation run according to current regulations (GMP, GLP).
Novelty – Pilot Plant (API manufacturing) completely renovated in the year 2006.
Reliability – over 55 years of successful cooperation with both domestic and foreign pharmaceutical companies and research centres, certified products and services.
Knowledge – the balance between scientific and industrial activities results in the proper direction of research, successful implementation of developed technologies as well as efficient intellectual property rights protection.
Manufacturing offer:
Active pharmaceutical ingredients (APIs) manufacturing in laboratory, kilolab and plant scale.
Contract manufacturing of oral dosage forms in laboratory and ¼-plant scale during technology development modifications.
Medicinal products manufacturing: soft capsules, oral drops, dry substances for solution preparation.
Other services:
Patent surveys in chemistry and pharmacy: API synthesis, polymorphism and pharmaceutical dosage forms.
Registration of medicinal products: preparation and evaluation of the registration documentation, organization of the registration and reregistration processes, post-registration changes, coordination of the information documents and expert reports preparation.
As east area director for the vast CEE market, Pawel Mazur explains how Accord Healthcare has gone from strength to strength in Poland, with the intention of becoming a top…
Krzysztof Popławski, general manager of Baxter Poland, discusses the Baxter Education Center, the largest educational program for a European affiliate, and its role in raising the awareness within the Polish…
Hubert Niemyjski, country manager of Coloplast Poland and the Baltics, highlights the large differences between the market landscape of the company’s three pillars; ostomy, wound and continence care. Additionally, he…
Olympus is internationally well-regarded as being a quality camera provider and continues to provide developed countries across the globe with high-tech medical devices from endoscopes to imagery solutions. Tomasz Mrzygłód,…
Paweł Migdalski, CEO at Siemens Healthineers Poland, discusses the innovations they are bringing to the market and how they are building on the success of the Siemens Healthineers Academy. Furthermore,…
Tomasz Dzitko, founder and CEO of Delfarma, Poland’s leading parallel importer, gives an overview of the sector in Poland and its impact on the healthcare ecosystem, as well as the…
Piotr Steczniewski, president of Profarm PS – a successful wholesale family business – since 2012, shares how the company has managed to thrive over the years through constant adaptation to…
Łukasz Korybalski, regional manager of Becton Dickinson (BD) Central Eastern Europe, discusses the rising significance of the region as the company continues to grow and the strategic importance of Poland,…
Marzena Kulis, managing director of Johnson & Johnson Medical Devices CEE, highlights the importance of the region and Poland within J&J Medical Devices, and the impact of increasing healthcare expenditures…
Despite the global R&D excitement around oncology, cardiovascular death still remains the world’s largest killer, and according to OECD data, accounts for roughly a third of all mortalities. This trend…
Cezary Kilczewski, president and founder of Medicofarma, a Polish CMO, discusses the company’s recent upgrades to double production capacity and the move into R&D operations as well as the dynamics…
Andrzej Schonert, CEO of Synoptis Industrial, discusses the intricacies of the Polish market and the requirement to move into niche areas, mainly in Rx, to concentrate their pharmaceutical offering to…
See our Cookie Privacy Policy Here